Investor Relations
Reporting Q2 2021
Evonik has published its quarterly report Q2 2021 on August 5, 2021. You can access further information here. ... MORE
Investor Relations
Annual shareholders’ meeting 2021
The Annual Shareholders‘ Meeting 2021 of Evonik Industries AG took place on June 2, 2021. Detailed information on the Annual Shareholders’ Meeting is available in the archive. The Annual Shareholders’ Meeting 2022 is scheduled to take place on May 25, 2022. ... MORE
Events
Division Spotlight Series
After the successful implementation of our new division structure in 2020, we take it a step further this year:
We are hosting a "Division Spotlight Series" for our three growth divisions over the first half of 2021. ... MORE
Further Information
Company
Events & Presentations
Here you will find dates, information and presentations on our events. ... MORE
Company
Analysts' estimates
Evonik Industries AG is covered by German and international financial analysts, who provide their own research analyses and earnings estimates in respect of the company. ... MORE
Company
News & Reports
Here you can find "Investor Relations News" with the latest news from our company, plus our most recent interim reports, annual reports and corporate responsibility reports. ... MORE
Reporting 2021
-
August 5, 2021Quarterly Report Q2 2021
-
November 4, 2021Quarterly Report Q3 2021
-
March 3, 2022Quarterly Report Q4 2021
Investor Relations
Aug 26, 2021
Evonik successfully issues first green hybrid bond
Evonik Industries AG today successfully issued a first green hybrid bond with a nominal volume of €500 million. ... MORE
Investor Relations
Aug 05, 2021
Evonik grows strongly in the first half of the year and raises outlook for 2021
Evonik has raised its outlook for 2021 after posting strong earnings in the first half. ... MORE
Investor Relations
Jun 15, 2021
Evonik boosts its system solutions portfolio with the acquisition of the cosmetic delivery company Infinitec Activos
Essen, Germany. Evonik has signed a purchase agreement to acquire the privately owned technology-driven company Infinitec Activos, with closing expected by July. ... MORE
Investor Relations
Jun 10, 2021
Evonik and Stanford University sign research collaboration: Evonik to market and develop new drug delivery platform for mRNA and gene therapy
Essen, Germany. Evonik is working with Stanford University on a technology to deliver mRNA to tissues and organs that goes beyond the capabilities of lipid nanoparticles (LNPs). ... MORE
Investor Relations
Jun 02, 2021
Supervisory board extends contract with Christian Kullmann
Essen. Christian Kullmann, who has been chairman of Evonik's executive board since May 2017, will head this Essen-based specialty chemicals company for another five years. ... MORE
Investor Relations
May 06, 2021
Evonik more confident about full year after a strong first quarter
Evonik is more positive about its earnings for the year as a whole after posting a strong first quarter. ... MORE
Further Information
Company
Financial data
Evonik is active in over 100 countries around the world. In fiscal 2018 more than 36,000 employees generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.6 billion. ... MORE
Company
Bonds & Rating
Evonik maintains a centralized approach to financing. Liabilities for credit and loans are fully guaranteed by Evonik Industries AG. ... MORE
Company
Key Figures Share
Here you find information about Evonik shares. ... MORE
Company
Contact & Service
You can find the contacts in the Investor Relations Department here. ... MORE
Company
Disclaimer
Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained. ... MORE
Company
Corporate Governance
As a globally active company, we have to comply with a wide range of statutory regulations and cultural standards. ... MORE
Investor Relations
Sustainable Investment (SRI)
We accept responsibility for our businesses, our employees, the environment and the society. ... MORE